Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0580
0.00 (0.00%)
Sep 8, 2025, 3:09 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 13.83 million as of September 8, 2025. Its market cap has increased by 92.38% in one year.
Market Cap
13.83M
Enterprise Value
14.32M
Revenue
1.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 13.83M, a decrease of -85.47%. That is a compound annual growth rate of -32.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 13.83M | 126.19% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | 84.16M | -11.61% |
| Oct 22, 2020 | 95.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 22.25B |
| EBOS Group | 6.27B |
| Ryman Healthcare | 2.62B |
| Summerset Group Holdings | 2.57B |
| Oceania Healthcare | 506.96M |
| AFT Pharmaceuticals | 283.14M |
| Pacific Edge | 144.12M |
| Green Cross Health | 129.35M |